Exact Mass: 555.1952
Exact Mass Matches: 555.1952
Found 359 metabolites which its exact mass value is equals to given mass value 555.1952
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Demethyldecarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the 3-O-carbamoyl and 4-O-methyl groups from the hexose ring.
Tiapamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
15-Demethylaclacinomycin T
An anthracycline obtained by hydrolysis of the methyl ester group of aclacinomycin T.
Fiduxosin
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
N-Fructosyl S-(2-carboxypropyl)glutathione
Annotation level-3
Isoflavone base + 1O, 1MeO, O-Hex+C7H12NO
Annotation level-3
1Z,-Isomer-Tunichrome An1|tunichrome B-1|Tunichrome B1
2-amino-5-[(5-beta-D-glucopyranosyl-4-hydroxy-cyclopent-2-enylamino)-methyl]-7-beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
2-Desoxy-[5]adenylsaeure-thymidin-3-ylester|d(TpA)|TA|thymidilyl-(3<*>5)-2-deoxyadenosine|thymidylyl-(3->5)-2-deoxy-adenosine|TpA|TpdA
Glu Arg His Asp
Cys Asp Arg Tyr
Cys Asp Tyr Arg
Cys Phe Met Arg
Cys Phe Arg Met
Cys Phe Thr Trp
Cys Phe Trp Thr
Cys Met Phe Arg
Cys Met Arg Phe
Cys Arg Asp Tyr
Cys Arg Phe Met
Cys Arg Met Phe
Cys Arg Tyr Asp
Cys Thr Phe Trp
Cys Thr Trp Phe
Cys Trp Phe Thr
Cys Trp Thr Phe
Cys Tyr Asp Arg
Cys Tyr Arg Asp
Asp Cys Arg Tyr
Asp Cys Tyr Arg
Asp Glu His Arg
Asp Glu Arg His
Asp Phe Phe Gln
Asp Phe Gln Phe
Asp His Glu Arg
Asp His Arg Glu
Asp His Val Trp
Asp His Trp Val
Asp Lys Met Tyr
Asp Lys Tyr Met
Asp Met Lys Tyr
Asp Met Gln Tyr
Asp Met Tyr Lys
Asp Met Tyr Gln
Asp Gln Phe Phe
Asp Gln Met Tyr
Asp Gln Tyr Met
Asp Arg Cys Tyr
Asp Arg Glu His
Asp Arg His Glu
Asp Arg Tyr Cys
Asp Val His Trp
Asp Val Trp His
Asp Trp His Val
Asp Trp Val His
Asp Tyr Cys Arg
Asp Tyr Lys Met
Asp Tyr Met Lys
Asp Tyr Met Gln
Asp Tyr Gln Met
Asp Tyr Arg Cys
Glu Asp His Arg
Glu Asp Arg His
Glu Phe Phe Asn
Glu Phe Asn Phe
Glu His Asp Arg
Glu His Arg Asp
Glu Met Asn Tyr
Glu Met Tyr Asn
Glu Asn Phe Phe
Glu Asn Met Tyr
Glu Asn Tyr Met
Glu Arg Asp His
Glu Tyr Met Asn
Glu Tyr Asn Met
Phe Cys Met Arg
Phe Cys Arg Met
Phe Cys Thr Trp
Phe Cys Trp Thr
Phe Asp Phe Gln
Phe Asp Gln Phe
Phe Glu Phe Asn
Phe Glu Asn Phe
Phe Phe Asp Gln
Phe Phe Glu Asn
Phe Phe Asn Glu
Phe Phe Gln Asp
Phe Met Cys Arg
Phe Met Met Gln
Phe Met Gln Met
Phe Met Arg Cys
Phe Asn Glu Phe
Phe Asn Phe Glu
Phe Gln Asp Phe
Phe Gln Phe Asp
Phe Gln Met Met
Phe Arg Cys Met
Phe Arg Met Cys
Phe Thr Cys Trp
Phe Thr Trp Cys
Phe Trp Cys Thr
Phe Trp Thr Cys
Gly Met Trp Tyr
Gly Met Tyr Trp
Gly Trp Met Tyr
Gly Trp Tyr Met
Gly Tyr Met Trp
Gly Tyr Trp Met
His Asp Glu Arg
His Asp Arg Glu
His Asp Val Trp
His Asp Trp Val
His Glu Asp Arg
His Glu Arg Asp
His Arg Asp Glu
His Arg Glu Asp
His Val Asp Trp
His Val Trp Asp
His Trp Asp Val
His Trp Val Asp
Lys Asp Met Tyr
Lys Asp Tyr Met
Lys Met Asp Tyr
Lys Met Tyr Asp
Lys Tyr Asp Met
Lys Tyr Met Asp
Met Cys Phe Arg
Met Cys Arg Phe
Met Asp Lys Tyr
Met Asp Gln Tyr
Met Asp Tyr Lys
Met Asp Tyr Gln
Met Glu Asn Tyr
Met Glu Tyr Asn
Met Phe Cys Arg
Met Phe Met Gln
Met Phe Gln Met
Met Phe Arg Cys
Met Gly Trp Tyr
Met Gly Tyr Trp
Met Lys Asp Tyr
Met Lys Tyr Asp
Met Met Phe Gln
Met Met Gln Phe
Met Asn Glu Tyr
Met Asn Tyr Glu
Met Gln Asp Tyr
Met Gln Phe Met
Met Gln Met Phe
Met Gln Tyr Asp
Met Arg Cys Phe
Met Arg Phe Cys
Met Trp Gly Tyr
Met Trp Tyr Gly
Met Tyr Asp Lys
Met Tyr Asp Gln
Met Tyr Glu Asn
Met Tyr Gly Trp
Met Tyr Lys Asp
Met Tyr Asn Glu
Met Tyr Gln Asp
Met Tyr Trp Gly
Asn Glu Phe Phe
Asn Glu Met Tyr
Asn Glu Tyr Met
Asn Phe Glu Phe
Asn Phe Phe Glu
Asn Met Glu Tyr
Asn Met Tyr Glu
Asn Pro Tyr Tyr
Asn Tyr Glu Met
Asn Tyr Met Glu
Asn Tyr Pro Tyr
Asn Tyr Tyr Pro
Pro Asn Tyr Tyr
Pro Tyr Asn Tyr
Pro Tyr Tyr Asn
Gln Asp Phe Phe
Gln Asp Met Tyr
Gln Asp Tyr Met
Gln Phe Asp Phe
Gln Phe Phe Asp
Gln Phe Met Met
Gln Met Asp Tyr
Gln Met Phe Met
Gln Met Met Phe
Gln Met Tyr Asp
Gln Tyr Asp Met
Gln Tyr Met Asp
Arg Cys Asp Tyr
Arg Cys Phe Met
Arg Cys Met Phe
Arg Cys Tyr Asp
Arg Asp Cys Tyr
Arg Asp Glu His
Arg Asp His Glu
Arg Asp Tyr Cys
Arg Glu Asp His
Arg Glu His Asp
Arg Phe Cys Met
Arg Phe Met Cys
Arg His Asp Glu
Arg His Glu Asp
Arg Met Cys Phe
Arg Met Phe Cys
Arg Tyr Cys Asp
Arg Tyr Asp Cys
Ser Thr Trp Tyr
Ser Thr Tyr Trp
Ser Trp Thr Tyr
Ser Trp Tyr Thr
Ser Tyr Thr Trp
Ser Tyr Trp Thr
Thr Cys Phe Trp
Thr Cys Trp Phe
Thr Phe Cys Trp
Thr Phe Trp Cys
Thr Ser Trp Tyr
Thr Ser Tyr Trp
Thr Trp Cys Phe
Thr Trp Phe Cys
Thr Trp Ser Tyr
Thr Trp Tyr Ser
Thr Tyr Ser Trp
Thr Tyr Trp Ser
Val Asp His Trp
Val Asp Trp His
Val His Asp Trp
Val His Trp Asp
Val Trp Asp His
Val Trp His Asp
Trp Cys Phe Thr
Trp Cys Thr Phe
Trp Asp His Val
Trp Asp Val His
Trp Phe Cys Thr
Trp Phe Thr Cys
Trp Gly Met Tyr
Trp Gly Tyr Met
Trp His Asp Val
Trp His Val Asp
Trp Met Gly Tyr
Trp Met Tyr Gly
Trp Ser Thr Tyr
Trp Ser Tyr Thr
Trp Thr Cys Phe
Trp Thr Phe Cys
Trp Thr Ser Tyr
Trp Thr Tyr Ser
Trp Val Asp His
Trp Val His Asp
Trp Tyr Gly Met
Trp Tyr Met Gly
Trp Tyr Ser Thr
Trp Tyr Thr Ser
Tyr Cys Asp Arg
Tyr Cys Arg Asp
Tyr Asp Cys Arg
Tyr Asp Lys Met
Tyr Asp Met Lys
Tyr Asp Met Gln
Tyr Asp Gln Met
Tyr Asp Arg Cys
Tyr Glu Met Asn
Tyr Glu Asn Met
Tyr Gly Met Trp
Tyr Gly Trp Met
Tyr Lys Asp Met
Tyr Lys Met Asp
Tyr Met Asp Lys
Tyr Met Asp Gln
Tyr Met Glu Asn
Tyr Met Gly Trp
Tyr Met Lys Asp
Tyr Met Asn Glu
Tyr Met Gln Asp
Tyr Met Trp Gly
Tyr Asn Glu Met
Tyr Asn Met Glu
Tyr Asn Pro Tyr
Tyr Asn Tyr Pro
Tyr Pro Asn Tyr
Tyr Pro Tyr Asn
Tyr Gln Asp Met
Tyr Gln Met Asp
Tyr Arg Cys Asp
Tyr Arg Asp Cys
Tyr Ser Thr Trp
Tyr Ser Trp Thr
Tyr Thr Ser Trp
Tyr Thr Trp Ser
Tyr Trp Gly Met
Tyr Trp Met Gly
Tyr Trp Ser Thr
Tyr Trp Thr Ser
Tyr Tyr Asn Pro
Tyr Tyr Pro Asn
alkali blue 4b
Serlopitant
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
Rucaparib Camsylate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor C471 - Enzyme Inhibitor
N-(Ethylsulfonyl)tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}glutamamide
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(7,7-Dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
(1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2R)-3-hydroxy-2-{[6-O-(6-O-octanoyl-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl]oxy}propanoate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[(1S,2R,4R,7Z,11S)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-12-yl]methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
15-demethylaclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the tertiary amino group of 15-demethylaclacinomycin T.
Tiapamil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(rel)-AR234960
(rel)-AR234960 is an active relative configuration of AR234960. AR234960, a non-peptide MAS (a G protein-coupled receptor) agonist, increases both mRNA and protein levels of CTGF via ERK1/2 signaling in HEK293-MAS cells and adult human cardiac fibroblasts[1].